- BETA DRUGS LIMITED
BETA DRUGS LIMITED Share Price
BETA
₹2,125.00+₹0.50 (0.02%) TodayLast updated on 18 Dec, 2024 | 15:07 IST
BETA DRUGS LIMITED Share Price Chart
Please wait...
Company overview
BETA DRUGS LIMITED Financials
Market cap  ₹2,042 Crs | Open ₹2,083.10 | Close ₹2,124.50 |
Circuit range ₹2,549.40 - ₹1,699.60 | Day range ₹2,020.00 - ₹2,125.00 | Year range ₹1,060.05 - ₹2,326.00 |
Volume 1,800 | Avg. traded ₹2,089.81 | Revenue (12m) ₹335 Crs |
BETA DRUGS LIMITEDBeta Drugs Limited is an India-based company, which is engaged in manufacturing of the wide range of anti-cancer drugs in India. The Company operates through manufacturing of Oncology medicines segment. The Company offers a portfolio consisting of approximately 50 products catering to various oncology diseases, including breast, lung, head, and neck, colorectal, ovarian, gastric, brain, testicular renal, prostate, leukemia, lymphoma, myeloma, supportive. The Company’s oncology portfolio includes various brands, such as AB-PACLI, ADBIRON, ADCARB, ADCIST, Adlante, ADLEAP, ADMIDE, ADOXI, CAPAD, ARBAZ, FISTENT, BUSFAN, Triodelta and others. The Company's subsidiaries include Adley Lab Limited, Adley Formulations Private Limited.
BETA DRUGS LIMITED Key indicators
52 week high ₹2,326.00 | 52 week low ₹1,060.05 | P/E ratio 49.81 |
P/B ratio 13.68 | ROE 20.67% | ROCE 27.27% |
Dividend yield -- | Debt/Equity ratio 0.05 | EPS 22.82 |
Learn more
Sector
Investment checklist: (5/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
BETA DRUGS LIMITED Fundamentals
BETA DRUGS LIMITED Financial Ratios
Operating profit margin17.84% | Net profit margin11.1% |
ROE20.67% | ROA14.06% |
ROCE27.27% |
Quick ratio1.92 | Current ratio2.24 |
Interest coverage29.15 | Asset turnover1.27 |
Debt to Equity0.05 |
P/E ratio49.81 | P/B ratio13.68 |
EV / EBITDA33.03 | |
Dividend yield0% |
Learn more
BETA DRUGS LIMITED Shareholder returns
1 day | 1 week -5.65% | 1 month |
3 months | 1 year | 3 years |
5 years |
Revenue statement
All values are in ₹ Crores (Cr)Learn more
Cash flow
All values are in ₹ Crores (Cr)Learn more
Balance sheet
All values are in ₹ Crores (Cr)Total assets
Total liabilities
Learn more
BETA DRUGS LIMITED Share Price history
| Day | Open | Close | Change % |
|---|---|---|---|
Tue, Dec 17 2024 | ₹2,068.30 | ₹2,124.50 | |
Mon, Dec 16 2024 | ₹2,171.25 | ₹2,085.95 | -3.93% |
Fri, Dec 13 2024 | ₹2,160.00 | ₹2,171.25 | -1.28% |
Thu, Dec 12 2024 | ₹2,270.00 | ₹2,199.45 | -1.59% |
Wed, Dec 11 2024 | ₹2,251.75 | ₹2,235.05 | -0.74% |
Tue, Dec 10 2024 | ₹2,251.00 | ₹2,251.75 | |
Mon, Dec 9 2024 | ₹2,190.00 | ₹2,221.80 | |
Fri, Dec 6 2024 | ₹2,240.00 | ₹2,198.10 | -1.99% |
BETA DRUGS LIMITED Shareholding Pattern
Promoters (66.73%) | Mutual Funds (0%) | Retail and other (31.96%) |
Foreign institutions-FII (1.15%) | Other domestic institutions (0.15%) |
Promoters
Learn more
More
Stocks Similar to BETA DRUGS LIMITED
Popular Stocks
FAQs on BETA DRUGS LIMITED
What is the BETA DRUGS LIMITED share price today?
BETA DRUGS LIMITED share price is ₹ 2,125.00 today.
What is today’s high & low share price of BETA DRUGS LIMITED?
BETA DRUGS LIMITED share price high: ₹ 2,125.00 and low: ₹ 2,020.00
What is the BETA DRUGS LIMITED share price high and low in the last 52 weeks on the NSE?
52 Week share High Price is ₹ 2,326.00 and Low Price is ₹ 1,060.05
What is the BETA DRUGS LIMITED Stock Symbol?
The BETA DRUGS LIMITED Stock symbol is BETA.
Can I buy BETA DRUGS LIMITED shares on Holidays?
No, shares of BETA DRUGS LIMITED or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell BETA DRUGS LIMITED shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.